Flat-rate pricing · Savings with longer plans Prescription included · 100% online · No lab work required · Dose adjustment supported · Free consultation Free shipping · Supplies included · Discreet packaging Money-back guarantee Tirzepatide, Semaglutide · Zepbound, Mounjaro, Ozempic, Wegovy Available in all 50 states $135/mo membership fee · Best pricing requires prepaid commitment Membership required for brands · Auto-renewing plans · Cancellation terms apply Video consultation required · BMI requirement for eligibility Pharmacy data not disclosed Trustpilot below averageProvider Plans Monthly Plan Tirzepatide Monthly
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $449.00 10mg $449 $44.90/mg 5.0mg/wk 20mg/mo $449.00 20mg $449 $22.45/mg 7.5mg/wk 30mg/mo $449.00 30mg $449 $14.97/mg 10.0mg/wk 40mg/mo $449.00 40mg $449 $11.22/mg 12.5mg/wk 50mg/mo $449.00 50mg $449 $8.98/mg 15.0mg/wk 60mg/mo $449.00 60mg $449 $7.48/mg
3-Month Package Tirzepatide Bundle Ships Upfront
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 30mg/total $1053.00 30mg $351 $35.10/mg 5.0mg/wk 60mg/total $1053.00 60mg $351 $17.55/mg 7.5mg/wk 90mg/total $1053.00 90mg $351 $11.70/mg 10.0mg/wk 120mg/total $1053.00 120mg $351 $8.78/mg 12.5mg/wk 150mg/total $1053.00 150mg $351 $7.02/mg 15.0mg/wk 180mg/total $1053.00 180mg $351 $5.85/mg Membership fee included
Starter Plan Tirzepatide Starter
Starter Sale: $100 off $349/avg
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $349.00 $449.00 10mg $349 $34.90/mg 5.0mg/wk 20mg/mo $349.00 $449.00 20mg $349 $17.45/mg 7.5mg/wk 30mg/mo $349.00 $449.00 30mg $349 $11.63/mg 10.0mg/wk 40mg/mo $349.00 $449.00 40mg $349 $8.72/mg 12.5mg/wk 50mg/mo $349.00 $449.00 50mg $349 $6.98/mg 15.0mg/wk 60mg/mo $349.00 $449.00 60mg $349 $5.82/mg Sale price included · Converts To Monthly Plan After Term
Mounjaro Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $135.00 10mg $135 N/A 5.0mg/wk 20mg/mo $135.00 20mg $135 N/A 7.5mg/wk 30mg/mo $135.00 30mg $135 N/A 10.0mg/wk 40mg/mo $135.00 40mg $135 N/A 12.5mg/wk 50mg/mo $135.00 50mg $135 N/A 15.0mg/wk 60mg/mo $135.00 60mg $135 N/A Membership fee included
Zepbound Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $135.00 10mg $135 N/A 5.0mg/wk 20mg/mo $135.00 20mg $135 N/A 7.5mg/wk 30mg/mo $135.00 30mg $135 N/A 10.0mg/wk 40mg/mo $135.00 40mg $135 N/A 12.5mg/wk 50mg/mo $135.00 50mg $135 N/A 15.0mg/wk 60mg/mo $135.00 60mg $135 N/A Membership fee included
Provider Details In-House Rx Dose Adjustments By Provider
Prescription Included Yes
Telehealth Included Yes
Online-Only Option Yes
Skip Labs Yes
Credit Money-Back Guarantee Membership Sale: $96 off first month Starter Sale: up to $100 off
Insurance Accepted Yes
HSA/FSA Accepted Yes
Financing Available Not Disclosed
Sale Yes
LegitScript Certified Not Disclosed
HIPAA Compliant Yes
Mobile App Yes
Supplies Included Cold-Packed
Free Shipping Yes
Expedited Shipping No
Discreet Packaging Yes
Format: Injection Brands: Ozempic Pen · Wegovy Pen · +2
Offers Tirzepatide Yes
Offers Semaglutide Yes
Offers Brand Yes
Other Treatments Yes
Live Chat Mon-Fri 9 AM-6 PM EST Sat-Sun 12 PM-6 PM EST
Phone (877) 870-0323
Address 30 Irving Pl, New York, NY 10003
Provider Notes Compliance Zealthy also sells medication through Google Shopping. The coaching page states that coaching is only available through Zealthy's subscription programs and is not included in medication purchases made through that route.
The Zealthy Weight Loss Program is not available to members using government insurance plans such as Medicare or Medicaid. Availability is otherwise all 50 states.
Prior authorization for brand-name GLP-1 coverage is submitted by Zealthy's insurance coordination team. An active membership is required to maintain the prior authorization.
The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.